there was some stable level of visual recognition impairment; a fully developed Capgras syndrome, however, only appeared in association with a psychotic relapse. Within the framework of the "salience theory" of psychosis (4,5), this suggests that increased dopamine mesolimbic neurotransmission associated with psychotic relapse adds salience, novelty, and in this case, aversive features, to a familiar, albeit misidentified, visual stimulus that would otherwise have remained neutral in a remitted patient. Once present, however, Capgras syndrome shares the stability and refractoriness of the underlying cognitive deficit.
Effectiveness of Risperidone in Delirium
Dear Editor: Delirium is a common and complex neuropsychiatric syndrome seen frequently in medical settings. If untreated, it is associated with high mortality (1) . Apart from a multifaceted interdisciplinary approach involving environmental strategies, antipsychotic medication remains the cornerstone of treatment (1). Among these drugs, the typical antipsychotic haloperidol has been the drug of choice, mainly owing to its lack of anticholinergic (1) and minimal hemodynamic and respiratory side effects (2) . Over the last decade, however, evidence has emerged for the use of second generation antipsychotics like risperidone-but only in the form of case reports and case series (3, 4) .
We report our experience in treating 7 cases of delirium with risperidone.
To identify the target group, we screened case notes of all patients with a diagnosis of delirium seen over a 4-year period. Seven patients who had delirium when assessed were treated with risperidone.
The demographic profile was as follows: the patients' mean age was 32 years (range 24 to 67 years); 60% were men, and 40% were women; they had on average 6 years of education; and 70% had low socioeconomic status. There was only 1 elderly woman (aged 67 years) with past cardiac problems and current hypoactive delirium. The rest of the sample had no past cardiac problems and presented with hyperactive delirium. The mean duration of delirium before initiation of treatment was 5.29 days (range 1 to 15 days, with the maximum for the elderly woman). All subjects were treated with environmental measures, correction of the underlying cause, and risperidone. The dosages of risperidone were as follows: average starting and maximum dosage was 1.14 mg daily (range 0.5 to 2.0 mg daily); the average dosage through the period of treatment was 1.07 mg daily (range 0.5 to 1.5 mg daily). All patients were closely monitored (at least once every 48 hours.) No subject developed observable extrapyramidal or any other serious side effects. All patients, except for the elderly woman, were either significantly improved or recovered at the last follow-up. This small, open-label, retrospective case series demonstrates that risperidone in low doages is effective and safe for treating delirium.
Risperidone possesses certain advantages over haloperidol, specifically, fewer extrapyramidal and cardiac side effects, including a reduced propensity to cause QT prolongation (5) . This profile, along with a lowdosage regime, gives it a unique advantage over haloperidol. However, the current lack of an available intravenous parenteral formulation, as well as the lack of a large database on risperidone use in treating delirium, may preclude its use as a standard or textbook treatment modality. Controlled, double-blind, prospective studies are warranted to establish the efficacy of risperidone as a useful alternative to haloperidol in treating delirium.
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Family-Oriented Rehabilitation for Unexplained Chronic Pain
Dear Editor: We present a case report to illustrate our experience with a family-oriented rehabilitation program for children and adolescents suffering from unexplained chronic pain.
Case Report
A girl, aged 12 years, had a 6-month history of unexplained abdominal pain described as a "hurt feeling inside," fatigue, decreased concentration, sleep difficulty, and school avoidance. She was described as an excellent student and a perfectionist in all her activities. Consultations from a pediatrician, gastroenterologist, neurologist, and allergist ruled out significant organic pathology to explain her symptoms. Her parents were angry that a medical cause was not found and denied the existence of psychosocial stressors. The child's aunt had recently died from a tumour that presented with unexplained pain symptoms for months prior to diagnosis.
Psychometric testing revealed an anxious coping style and perfectionist traits. During the assessment, the family expressed their feelings of anger about their aunt's death and began to confront their unresolved grief. The patient began taking fluvoxamine 100 mg every night. As a goal of rehabilitation, we emphasized enhanced functioning, specifically, improved sleep, increased activities, Can J Psychiatry, Vol 50, No 1, January 2005 W 75
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